Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | PRKD1 | Q15139 | 6/20 | 0.44 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HTR5A | P47898 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.40 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12651075 | 0.93 | PRKD1 (0.49) | HDAC1PRKD1CRBNMEN1RAB9A | |
| Trifluoroacetic Acid SCHEMBL3341197 | 0.91 | EPHX2 (0.52) | HDAC1PRKD1SLC2A1MEN1RAB9A | |
| Trifluoroacetic Acid SCHEMBL3338278 | 0.89 | OPRM1 (0.50) | HDAC1PRKD1SLC2A1PDK2MEN1 | |
| Trifluoroacetic Acid SCHEMBL3340179 | 0.88 | HTR5A (0.45) | HDAC1PRKD1SLC2A1RAB9AHTR5A | |
| Trifluoroacetic Acid SCHEMBL3340242 | 0.87 | HTR5A (0.46) | HDAC1SLC2A1RAB9AHTR5AEPHX2 | |
| Trifluoroacetic Acid SCHEMBL3340372 | 0.86 | OPRM1 (0.44) | HDAC1PRKD1SLC2A1RAB9AHTR5A | |
| SCHEMBL12651503 | 0.84 | EPHX2 (0.58) | HDAC1PRKD1MEN1RAB9AKMT2A | |
| Trifluoroacetic Acid SCHEMBL1789142 | 0.83 | SLC2A1 (0.43) | HDAC1SLC2A1MEN1RAB9AKMT2A | |
| Trifluoroacetic Acid SCHEMBL16194671 | 0.83 | PRKD1 (0.43) | HDAC1PRKD1SLC2A1MEN1RAB9A | |
| Trifluoroacetic Acid SCHEMBL3340025 | 0.82 | OPRM1 (0.47) | OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140323487-A1 | Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors | GLAXOSMITHKLINE LLC | 2014-10-30 | — | — | US | disclosed |
| US-20100113512-A1 | METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | IGNAR DIANE MICHELE | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113512-A1 | METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | OPRL1, OPRD1, OPRK1 | HDAC1 1478/4885PRKD1 2867/4885SLC2A1 2287/4885 |
| US-20140323487-A1 | Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors | OPRL1, OPRM1, OPRK1 | HDAC1 2440/4885PRKD1 3367/4885SLC2A1 4173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.